IOZK - Immuno-Oncological Centre Cologne

Specialists in immuno-oncology
Cologne, Germany

  - Iozk_logo_8

Information about IOZK - Immuno-Oncological Centre Cologne

Treatment focus

  • Systemic advice and care for cancer patients
  • Immunological tumour therapy (antibody therapy)
  • Autologous tumour vaccination
  • Hyperthermia procedures
  • Tumour-specific immune system activation
  • Adjuvant tumour-specific immuno-modulation

Medical range

Range of diagnostic services

  • Systemic advice from experienced doctors in the field of immuno-oncology
  • Determination of the individual immunological status
  • Tumour staging

 

Range of therapeutic services

  • Immunological oncology
  • tumour vaccination
  • Antibody therapy (immuno-oncology)
  • Supporting measures to strengthen the patient’s own immune system
  • Supplementary hyperthermia (e.g. locoregional radiofrequency hyperthermia, transurethral radiofrequency hyperthermia, and moderate whole-body hyperthermia)

About

The IOZK in Cologne specialises in individual cancer therapy with specific activation of the immune system. The team of supervising physicians and experienced scientists work together in a multidisciplinary manner. Here, findings from basic immunological research are directly implemented to treat cancer patients. The IOZK thus offers important therapy options that supplement and carry forward conventional therapies of tumour treatment.

Specialists in personalised cancer therapy

Since 1985, the immuno-oncological centre has been working extensively on the role of the immune system in the context of tumour diseases. For the first time in Europe, doctors and scientists have been able to obtain the authorisation to manufacture an autologous (the patient’s own) tumour vaccine in combination with these viruses in accordance with the Medicinal Products Act for “innovative therapies”. The use of the vaccine is often combined with further innovative therapies. For example, hyperthermia is used at the IOZK. The tumour vaccine can generally be used for all solid tumours (e.g. glioblastoma, prostate carcinoma, colon cancer, liver tumours, lung cancer, and partially also leukaemia).  The form of therapy most suitable for the patient depends on individual factors. If you have any questions, please do not hesitate to contact the specialists at the IOZK.

Targeted tumour therapy

The patient receives a customised therapeutic agent; the preparation of the individual vaccine is directed precisely at the patient’s cancer cells in order to attack and destroy them. The IOZK is among one of the pioneers in the field of personalised medicine. The tumour vaccine is based on autologous dendritic cells loaded with tumour antigens from the patient as well as a tumour-destroying virus. Through vaccination, the immune system is stimulated to fight against the tumour cells. Dendritic cells are part of our immune system and are responsible for presenting it with foreign substances (antigens) and thereby activating it. The side effects of tumour vaccination are comparatively low. In the days after vaccination, some patients notice a slight flu-like infection indicating that the immune system has been activated. The specialists at the IOZK strengthen and activate the patient’s defence system so that it can combat tumour growth.

Improvement of lifespan and quality of life

The novel treatment method of the IOZK was initially used mainly in patients with advanced tumour lesions for whom other treatment options had already been exhausted and a complete cure was seldom possible. New studies show that especially the very early use of the tumour vaccine offers the possibility to slow the course of the disease, thereby extending the lifespan and improving the quality of life. It is therefore helpful if patients turn to the IOZK as early as possible on their own initiative.

Until only a few years ago, tumour radiation or chemotherapy were the only alternatives if surgical removal of the tumours was not possible. These methods are associated with severe side effects.  This novel form of immunotherapy has led to the discovery of a treatment approach that is primarily directed against the tumour cells and causes significantly fewer side effects. The specialists at the IOZK have many years of experience in the field of immuno-oncological therapy and continue to develop it – to the benefit of the patients.

The website of the IOZK can be found here.

 

Expert Team

  • Dr Wilfried Stücker
    Pharmaceutical biology, neuropathic practitioner, focus on immunology/translational oncology, management
     
  • Prof Dr Volker Schirrmacher
    Scientific management, tumour immunology
     
  • Dr Stefaan Van Gool MD, PhD
    Specialist in paediatric haemato-oncology, immunologist, medical management of translational oncology
     
  • Dr med. Akos-Sigmund Bihari
    Specialist in general practice, doctor in charge of transfusion, qualified in pharmaceuticals, practice areas: immunology/integrative oncology
  • Dr med. Peter Seng
    Specialist in laboratory medicine, specialist in microbiology and infectious epidemiology
     
  • Dr med. Katharina Sprenger
    Specialist doctor in general medicine, doctor responsible for transfusions, qualified person for pharmaceuticals, pharmacovigilance
  • Dr med. Karin Ehlert
    Specialist doctor in general medicine, haemostaseology
     
  • Dr med. Tobias Sprenger
    Specialist in general practice, medical expert assessments
     
  • Dr Montassar Cherif, MD
    Doctor, practice areas: integrative oncology
     
  • Certified Biologist Gisela Feldmann
    Biologist, head of the GMP laboratory, pharmaceutical quality and biological safety officer
     
  • Dr Dirk Lorenzen
    Biologist, pharmaceutical quality and biological safety officer, qualified person for pharmaceuticals
     
  • Dr Maria Lulei
    Biologist, head of the immune-monitoring department
     

Videos


Location

Cologne Central Station

3 km

Cologne/Bonn Airport

15 km

Düsseldorf Airport  

60 km

Frankfurt Airport

180 km


Information about Cologne

Specialist doctors and medical centres in Cologne
MORE

Benefits programme on site

Excelsior Hotel Ernst Köln

The Excelsior Hotel Ernst is one of the last privately owned luxury hotels in the world. Family-owned since 1863, the 5 star luxury hotel fascinates guests from around the world. As the only member of the Leading Hotels of the World in Cologne, the Excelsior Hotel Ernst combines stylish tradition with modernity.

MORE

Steigenberger Hotel Cologne

Steigenberger Hotel Cologne is located in the heart of Cologne just a few minutes from historical sites. The famous cathedral and the Rhine Promenade is a mere 20 minute walk. Other attractions can be easily reached via metro or bus. The Rudolfplatz is located directly next to the hotel.

MORE

Steigenberger Parkhotel Düsseldorf

At the beginning of Düsseldorf's wonderful Königsallee awaits the Steigenberger Parkhotel. This elegant hotel is one of the best hotels in Düsseldorf. For more than 114 years, it has stood for modern tradition, cordial hospitality, and wonderful dining experiences.

MORE

Agent CS

Agent CS creates space so that you can concentrate on your most important tasks - an innovative service agency which uses existing networks in a wide variety of areas to provide you with a solution customised for you.

MORE

Lufthansa Mobility Partner

PRIMO MEDICO is an accredited partner of Lufthansa Health & Medical. Benefit as a member or user of PRIMO MEDICO from special terms that provide you and your travelling companion with discounts on a variety of fares offered by Lufthansa, SWISS, Austrian and brussels airlines.

MORE

Professional Aviation Solutions

Professional Aviation Solutions is a young, motivated team of experienced aircraft charter experts, which collaborates with only the most reputable airlines.

MORE
Contact

IOZK - Immuno-Oncological Centre Cologne


Hohenstaufenring 30-32, D-50674 Köln

T: +49 221 420 399 25
F: +49 221 420 399 26
E: iozk@primomedico.com

OUR GUIDELINES

OUR GUIDELINES

At PRIMO MEDICO, you will only find reputable medical authorities who were selected according to strict guidelines. Experience, innovative treatment techniques or reputation in science and research play an important role here.

MORE

Up